EyePoint Pharmaceuticals
EYPT
#5193
Rank
S$1.94 B
Marketcap
S$23.55
Share price
2.29%
Change (1 day)
98.40%
Change (1 year)

EyePoint Pharmaceuticals (EYPT) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : S$66.84 Million

According to EyePoint Pharmaceuticals 's latest financial reports the company's total liabilities are S$66.84 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

EyePoint Pharmaceuticals - Total liabilities on balance sheet (from 2003 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31S$0.11 B-5.07%
2023-12-31S$0.11 B4.23%
2022-12-31S$0.11 B5.44%
2021-12-31S$0.10 B10.31%
2020-12-31S$96.8 M11.08%
2019-12-31S$87.14 M
2018-06-30S$81.75 M1011.88%
2017-06-30S$7.35 M-49.17%
2016-06-30S$14.46 M19.3%
2015-06-30S$12.12 M25.54%
2014-06-30S$9.65 M-10.97%
2013-06-30S$10.84 M23%
2012-06-30S$8.82 M-25.75%
2011-06-30S$11.87 M-14.22%
2010-06-30S$13.84 M-29.31%
2009-06-30S$19.59 M-44%
2008-06-30S$34.98 M20.31%
2007-06-30S$29.07 M-59.3%
2006-06-30S$71.44 M356.52%
2005-06-30S$15.64 M577.83%
2004-06-30S$2.3 M123.48%
2003-06-30S$1.03 M
2001-06-30S$0.26 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
NRC Health
NRC
S$0.15 B 135.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
S$4.08 M-93.89% Bahamas